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The human receptor for poliovirus (CD155) is an immunoglobulin-like molecule with unknown normal function(s). Here we
provide evidence that CD155 binds specifically to vitronectin with a dissociation constant (Kd) of 72 nM as determined by
surface plasmon resonance. Based on sequence homology to the CD155 gene, three poliovirus receptor-related genes
(PRR1, PRR2, and PRR3) were cloned recently. PRR proteins were reported by others to mediate homophilic cell adhesion.
Neither PRR1 nor PRR2 binds poliovirus and it is assumed that their physiological functions differ from that of CD155. Indeed,
mPRR2 was found to bind to vitronectin only weakly, while its self-adhesion activity is characterized by a Kd of 310 nM.
Moreover, there is no evidence for CD155 self-adhesion. Both CD155 and vitronectin colocalize to follicular dendritic cells
and B cells inside the germinal centers of secondary lymphoid tissue (tonsils)—an observation suggesting that the
CD155/vitronectin interaction is required for the establishment of a proper immune response in this particular context.
© 2001 Academic Press
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mINTRODUCTION
CD155 is a single-pass transmembrane glycoprotein
belonging to the immunoglobulin (Ig) superfamily of
proteins. The extracellular portion of CD155 is com-
posed of three Ig-like domains: an outermost V-like
domain followed by two C2-like domains (Fig. 1; Wim-
mer et al., 1994). CD155 was originally discovered as
the cellular receptor for poliovirus (PV) (PVR; Koike et
al., 1990; Mendelsohn et al., 1989) with the binding
occurring between the V-like domain and the virion
(Wimmer et al., 1994). Although earlier studies indi-
cated that CD155 is widely distributed throughout hu-
man tissues, its level of expression is low and strin-
gently controlled (Freistadt, 1994; Solecki et al., 1997,
1999, 2000). Due to alternative splicing, the gene can
give rise to four different receptor proteins: two mem-
brane-bound receptors (CD155a and CD155d) and two
otentially secreted isoforms (CD155b and CD155g)
hich lack the transmembrane region (Bernhardt et
al., 1994a; Bibb et al., 1994a,b; Koike et al., 1990).
Whereas the interaction between PV and its receptor
was studied in great detail (Belnap et al., 2000; He et
al., 2000; Wimmer et al., 1994), the physiological func-
tion(s) of CD155 remained obscure. CD155 is the
founding member of a growing family of related mol-a
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218ecules sharing the V-C2-C2 architecture. Tage4 was
identified as a tumor antigen overexpressed in rat
colon carcinomas (Chadeneau et al., 1994; Denis,
1998). In addition, three human poliovirus receptor-
related cDNAs (hPRR1, hPRR2, and hPRR3) were iden-
tified (Eberle et al., 1995; Lopez et al., 1995; Reymond
et al., 2000). Sequence comparisons revealed that
hPRR2 is the human counterpart of mPRR2, originally
termed MPH (Morrison and Racaniello, 1992; murine
pvr homolog, see Fig. 1 for the extracellular domains).
The latter was assumed mistakenly to represent the
murine homolog of CD155. Thus, homologs of CD155
could be identified only in monkeys (Aoki et al., 1994;
Koike et al., 1992), suggesting that these receptors are
unique to primates. Based on recent evidence, Baury
et al. hypothesized that rat Tage4 is the rodent ho-
molog of CD155 (Baury et al., 2001). However, se-
quence features and chromosomal locations rather
indicate the existence of two subfamilies: CD155,
Tage4, and PRR2 may be grouped into a PVR subfam-
ily, whereas PRR1 and PRR3 represent the PRR sub-
family. Neither PRR1 nor PRR2 mediates entry of PV
into susceptible cells yet they serve as receptors for
different species of a-herpesviruses (Cocchi et al.,
000; Geraghty et al., 1998; Shukla et al., 1999). Apart
rom this pathogenic function, PRRs mediate ho-
ophilic cell adhesion and were shown to couple via
fadin, an actin filament binding protein, to the E-
adherin system (Aoki et al., 1997; Lopez et al., 1998;
219CD155 ADHESION TO VITRONECTINMiyahara et al., 2000; Tachibana et al., 2000; Taka-
hashi et al., 1999). Mice deficient in mPRR2 expression
were found to be sterile due to a defect in spermato-
genesis (Bouchard et al., 2000).
Vitronectin is an important component of the extracel-
lular matrix and constitutes a major serum protein. It is
expressed abundantly by liver cells and secreted into the
blood stream (see Preissner, 1991, for a review). Vitro-
nectin was shown to bind several cell receptors predom-
inantly of the integrin type as well as various serum
factors. Therefore, vitronectin is implicated in diverse
processes such as cell attachment and migration, throm-
bosis, fibrinolysis, and neoplasia (reviewed by Schvartz
et al., 1999). Moreover, vitronectin has been assigned a
role in cell differentiation during embryogenesis (Mar-
tı´nez-Moralez et al., 1997). Another important feature re-
lates to the binding of vitronectin to proteins of the
complement system—an interaction resulting in the in-
hibition of the complement cascade (Preissner, 1991).
Despite these multiple roles, knockout mice deficient for
vitronectin develop normally (Zheng et al., 1995) but
show an increased rate of thrombus formation (Fay et al.,
1999).
FIG. 1. Schematic representation of the recombinant receptors
sCD155d1d3, sCD155d1d2aglc, and smPRR2d1d3. Circles denote the
Ig-like domains: V for variable, C for constant. Receptors were tagged
with a His epitope. Asterisks indicate N-linked glycosylation sites.
Numbers in parentheses (smPRR2) indicate the degree of sequence
homology in percentage between the Ig-like domains of CD155 and
mPRR2.Here we report that CD155 binds specifically to vitro-
nectin. The vitronectin/CD155 interaction is distin-guished by a rapid complex formation and a dissociation
constant of 72 nM. Furthermore, CD155 and vitronectin
are coexpressed on follicular dendritic cells and B cells
inside germinal centers of secondary lymphoid organs.
The significance of these findings will be discussed.
RESULTS
To investigate the interaction of CD155 with compo-
nents of the extracellular matrix, adhesion assays were
performed using human vitronectin as substrate. HEp2
cells known to express CD155 were found to attach
readily to vitronectin-coated plastic wells. Monoclonal
antibodies (mAb) D171 and P44, which recognize CD155,
were found to reduce binding of the cells to vitronectin
significantly, whereas an unrelated isotype control anti-
body (9E10) exerted no effect (Fig. 2a, closed bars). Since
mAbs D171 and P44 completely block the interaction
between PV and the V-like domain of CD155 (reviewed by
Wimmer et al., 1994), our observations indicate that the
V-like domain may also be involved in vitronectin binding.
When HEp 2-Cl32 cells lacking CD155 expression were
used in the assays, inhibition of binding by D171 or P44
was marginal and most likely resulted from nonspecific
interactions (Fig. 2a, open bars). However, it should be
noted that even in the presence of saturating amounts of
either D171 or P44, or a combination thereof, binding of
the HEp 2 cells to the substrate was not completely
abolished (data not shown). This observation suggested
that a second receptor might be involved in cell/sub-
strate attachment. Therefore, mAb 23C6, known to block
the adhesive function of the classical vitronectin receptor
avb3, was used in these binding assays. MAb 23C6
caused a considerable reduction of HEp 2 cell binding
(Fig. 2b, closed bars). Similar to the D171 blocking ex-
periments, an increase in the concentration of mAb 23C6
up to 10-fold did not further reduce binding (data not
shown). In contrast, a combination of mAbs D171 and
23C6 resulted in almost background levels of HEp 2 cell
binding. As anticipated, the attachment of HEp 2-Cl32
was also affected by mAb 23C6, albeit to a slightly lesser
degree compared to HEp 2 cells (Fig. 2b, open bars). The
combined application of antibodies 23C6 and D171 had
no additive effect on HEp 2-Cl32 binding to vitronectin.
As expected, the isotype control mAb 9E10 did not re-
duce binding of HEp 2-Cl32 cells (Fig. 2b).
The bulky antibodies forming a complex with CD155
might have masked vitronectin-binding epitopes that
were provided by molecules located in direct proximity to
CD155. Indeed, it has been reported that CD155 is phys-
ically associated with CD44 on human mononuclear
blood cells (Freistadt and Eberle, 1997). In addition, our
own analyses confirmed expression of CD44 on HEp 2
cells, as well as on HEp 2-Cl32 cells (data not shown).
Therefore, a recombinant protein consisting of the
ectodomain of the receptor (sCD155d1d3, Fig. 1) was
r
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applied. (b) Inhibition of binding of HEp 2 cells (closed bars) and HEp
2-Cl32 cells (open bars) to vitronectin by 10 mg of mAb 23C6, an avb3
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220 LANGE ET AL.produced and used in competition experiments. The
structural integrity of sCD155d1d3 was confirmed by its
ability to reduce the titer of PV approximately 500-fold
(see Materials and Methods). The recombinant protein
sCD155d1d3 was found to decrease binding of HEp 2
cells to vitronectin by 75% relative to the control (Fig. 2c).
Under these experimental conditions, the binding of HEp
2-Cl32 cells to the substrate was reduced by approxi-
mately 20% (data not shown).
Almost half of the molecular mass of CD155 is con-
tributed by sugar chains (Fig. 1; Bernhardt et al., 1994a).
Since vitronectin is known to interact with carbohydrate-
derived ligands, it was of interest to determine whether
the sugar moiety of CD155 contributes to vitronectin
binding. A recombinant protein consisting of the two
N-terminal CD155 domains but lacking four of the five
putative N-glycosylation sites (Fig. 1, sCD155d1d2aglc)
(Bernhardt et al., 1994b), was expressed in CHO cells
and purified. Recombinant protein sCD155d1d2aglc in-
terfered with HEp 2 cell binding to vitronectin to an extent
comparable to that of sCD155d1d3 (Fig. 2c). These data
suggest that the CD155/vitronectin interaction is medi-
ated by an epitope residing in the V-2C domains, most
likely the N-terminal V-like domain (see above). Since the
V-like domain of recombinant sCD15d1d2aglc is devoid
of N-linked glycomodifications, it is conceivable that this
interaction is independent of the glycosylation pattern of
CD155.
These experiments were followed by dot blot assays
applying sCD155d1d3 as a detector (see Materials and
Methods). Polypeptide sCD155d1d3 specifically recog-
nized vitronectin but not filter-bound collagen type IV or
BSA (Fig. 3). In addition, we observed specific binding of
sCD155d1d3 to bovine and rat vitronectin, albeit at
slightly reduced levels compared to human vitronectin
(data not shown).
The specific interaction between CD155 and vitronec-
tin was then quantitated by surface plasmon resonance
(BIAcore). In these experiments the proteins of interest
(ligands, see also Tables 1 and 2) are immobilized onto
a sensor chip. The putative interaction with another sol-
uble entity (the analyte, here soluble recombinant CD155
or mPRR2) is subsequently monitored under constant
flow conditions, varying the concentrations of the analyte
under investigation. As a result, on and off rates as well
as the dissociation constant (K d) of a distinct binding
eaction can be determined. MAb D171 bound to
CD155d1d3 with a K d of 8 nM (see Table 1), suggesting
that this approach is suitable to study the interaction of
integrin-specific antibody, or by mixtures of 10 mg mAb 23C6 with either
0 mg D171 or 50 mg 9E10, as indicated. (c) Binding of HEp 2 cells
100%) compared to the binding in the presence of 10 mg of BSA,
sCD155d1d3, or sCD155d1d2aglc. All assays were done at least threeFIG. 2. Binding of HEp 2 and HEp 2-Cl32 cells to nitronectin. Vitro-
nectin was coated onto 96-well plastic dishes (see Materials and
Methods for details). (a) Inhibition of binding of HEp 2 (closed bars) and
HEp 2-Cl32 cells (open bars) to vitronectin-coated dishes in the ab-
sence (100%) or the presence of 50 mg of mAb as indicated. In the case
f D171/P44 (both mAbs are directed against CD155) a 1:1 mixture was
times in duplicate. Shown are the means; SD (standard deviations) are
indicated by error bars.
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221CD155 ADHESION TO VITRONECTINCD155 with putative ligands. sCD155d1d3 bound to hu-
man vitronectin with a K d of 72 nM. In contrast, the K d
values for the interaction of sCD155d1d3 with human
collagen type IV and BSA were 46 and 21 mM, respec-
ively. K d values in the latter range were considered to
represent nonspecific binding.
Similar binding experiments were carried out with
mPRR2, a mouse receptor related to CD155. For this
purpose, the ectodomain of mPRR2 (smPRR2d1d3; see
Fig. 1) was expressed in insect cells and purified. Rat
vitronectin, displaying a very high degree of conservation
compared to mouse vitronectin, was chosen as a sub-
strate (Otter et al., 1995). Polypeptide smPRR2d1d3
bound to rat vitronectin with a K d of 5 mM. As shown in
able 2, we have confirmed the homophilic interaction
etween smPRR2d1d3 molecules (K d of 310 nM). Based
n experiments in which mPRR2 was expressed on the
urface of insect cells, this property has already been
escribed (Aoki et al., 1997). In similar assays we ex-
ressed membrane-bound CD155 in insect cells in order
o check for cell clustering. However, such cells failed to
TABLE 1
Rate Constants for sCD155d1d3
Ligand K d (M) Off rate (s
21) On rate (M21 s21)
D171 8.1 3 1029 8.0 3 1023 9.8 3 105
hVn 7.2 3 1028 7.4 3 1023 1.0 3 105
hColIV 4.6 3 1025 5.2 3 1023 102
SA 2.1 3 1025 5.1 3 1023 234
Note. Shown are the means of at least three experiments with the
FIG. 3. Binding of sCD155d1d3 to various substrates. Human vitro-
nectin (hVn), human collagen type IV (hColIV), and BSA were spotted
onto nitrocellulose. Binding of sCD155d1d3 was monitored as de-
scribed under Materials and Methods. The intensity reflecting the
amount of bound sCD155d1d3 was set to 1 in the case of BSA.isted ligands coupled onto the sensor chip (see Materials and Meth-
ds). hVn, human vitronectin; hColIV, human collagen type IV.ggregate (data not shown), confirming the notion of
thers that CD155 does not possess homophilic adhe-
ion potential (Aoki et al., 1997).
We then searched for the CD155/vitronectin interaction in
ivo and chose to investigate the expression of both mole-
ules in human tonsilar sections by immunohistochemistry.
pon ingestion, the first target of PV are the tonsils
Melnick, 1996), suggesting expression of CD155 in as yet
nidentified cell populations inside this secondary lym-
hoid tissue. Staining with mAb D171 revealed the pres-
nce of CD155 within the germinal centers (GC) (see Figs.
a and 4b). It was already shown earlier that vitronectin is
lso present in GCs (Halstensen et al., 1988). In order to
determine whether its expression overlapped that of
CD155, we used a specific antibody to visualize vitronectin
(see Figs. 4c and 4d). The colocalization of the two mole-
cules in GCs was evident when CD155 (red) and vitronectin
(green) were detected in dual staining experiments (Fig.
4h). GCs represent the sites of a secondary immune re-
sponse, are relatively short-lived, and possess a dynamic
structure. They are composed predominantly of B cells,
which undergo clonal expansion, hypermutation, positive or
negative selection, and memory B cell generation. These
processes are dependent upon the support by interdigitat-
ing cells, T cells, and follicular dendritic cells (FDC) (re-
viewed by Liu et al., 1996). Dual staining experiments would
suggest that in addition to the latter cell type (see Fig. 4e),
GC B cells express CD155 (see Figs. 5c and 5e). Appar-
ently, GC B cells differ from FDCs in expressing CD155 to
various extents (Figs. 5c and 5e). Concomitantly, we ob-
served a similar bias in the vitronectin staining pattern (see
Figs. 5d and 5f). In contrast, T cells were found to be devoid
of CD155 (Fig. 5a). T cells accumulate in the areas sur-
rounding the GC and only a few T cells are interspersed
among the cells comprising the GC. Therefore, it is possible
that FDCs and GC B cells bind vitronectin by expressing
CD155 on their surface (see colocalization of these mole-
cules in Figs. 4g, 5d, and 5f). This view is challenged by the
fact that vitronectin can interact with several other cell
receptors, most notably integrins (Preissner, 1991). How-
ever, we failed to detect a GC-specific staining using an
antibody directed against the human av chain (Fig. 5b).
TABLE 2
Rate Constants for smPRR2d1d3
Ligand K d (M) Off rate (s
21) On rate (M21 s21)
Vn 5.0 3 1026 7.7 3 1024 140
mPRR2 3.1 3 1027 5.8 3 1025 186
SA 1.5 3 1024 3.7 3 1023 25
Note. Shown are the means of at least three experiments with the
listed ligands coupled onto the sensor chip (see Materials and Meth-
ods). rVn, rat vitronectin.Interestingly, the av chain is part of almost all vitronectin
receptors of the integrin type, corroborating the finding of
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222 LANGE ET AL.others that integrin-like vitronectin receptors are absent on
cells inside the GCs (Castanos-Velez et al., 1995).
DISCUSSION
FIG. 4. Colocalization of CD155 and vitronectin on FDCs. Cryosec-
tions of human tonsils were stained with mAbs directed against CD155
(D171), vitronectin (clone Vn5-3), and follicular dendritic cells (HJ2), in
single (a–d) or double (e–h) staining experiments. The white bars
represent the indicated size in micrometers, whereas the molecule
detected is depicted in color on the top. Control denotes a cryosection
stained with an isotype control antibody for (b) D171, (d) clone Vn5-3,
and (f) HJ2.The identification of the cellular receptor of poliovirus
CD155) in 1989 led to the discovery of a new family of
(
sg-like molecules, termed PRRs (poliovirus receptor re-
ated; see Introduction). While the normal function(s) of
D155 remained enigmatic, PRRs were shown to serve
s homophilic adhesion receptors engaged in the estab-
ishment of tight adherens junctions. Therefore, these
olecules had been renamed nectins (nectin 1, 2, and 3;
akahashi et al., 1999).
In our search for ligands of CD155, we observed that
a cell line (HEp 2) expressing CD155 could bind to
vitronectin-coated matrices. We then found that this in-
teraction is mediated not only by CD155 but indepen-
dently also by an integrin. Corresponding antibodies (Fig.
2) could specifically block both binding events. The bind-
ing of HEp 2 cells to vitronectin was almost completely
inhibited in the presence of both antibodies (see Fig. 2b).
As expected, only the vitronectin-specific antibody inhib-
ited the attachment of cells lacking CD155 (HEp 2-Cl32),
whereas mAb D171 had little effect.
Soluble recombinant derivatives of CD155
(sCD155d1d3 and sCD155d1d2aglc, Fig. 1) competed
with binding of HEp 2 cells to vitronectin (Fig. 2c), an
observation supporting our conclusion of CD155-
mediated attachment. Direct evidence for an interac-
tion between vitronectin and sCD155d1d3 was ob-
tained in a filter-based adhesion assay (Fig. 3) and by
calculating dissociation constants using surface plas-
mon resonance experiments (Table 1). sCD155d1d2
bound to human vitronectin with a K d of 72 nM, a value
ithin the limits of K d’s determined for other vitronectin
igands such as heparin (10 nM) and uPAR (30 nM)
Preissner, 1991; Wei et al., 1994). In contrast, human
ollagen type IV and BSA displayed characteristics of
nonspecific binding (demonstrated by their low K d
values of 46 and 21 mM, respectively).
Similar experiments performed with a soluble form of
ouse PRR2/nectin-2 (smPRR2) revealed a low affinity of
PRR2 to rat vitronectin (K d of 5 mM, see Table 2). In
ontrast, the observed homophilic adhesion of smPRR2
s characterized by a K d of 310 nM, a value comparable
o those obtained for other Ig-superfamily proteins such
s N-CAM (K d of 64 nM; Retzler et al., 1996). The ho-
ophilic interaction of membrane-associated mPRR2/
ectin-2 may gain in strength since it has been specu-
ated that mPRR2/nectin-2 need to dimerize in cis in
rder to bind efficiently in trans (Miyahara et al., 2000).
Previous observations indicated that both vitronectin
nd CD155 are expressed in tissue of human tonsils.
herefore, we studied the distribution of these proteins
n this anatomical compartment making use of markers
pecific for CD155, vitronectin, T cells, GC B cells, and
DCs. In single or combined immunohistological stain-
ngs, it was evident that vitronectin (Fig. 4c) and CD155
Fig. 4a) colocalize inside the GC (Fig. 4h). The presence
f CD155 was also apparent on FDCs and GC B cellsFigs. 4e and 5d), where its expression overlapped sub-
tantially that of vitronectin. It is remarkable that GCs are
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223CD155 ADHESION TO VITRONECTINdevoid of other important ECM components such as
collagens, laminin, fibronectin, and tenascin (Castanos-
Velez et al., 1995). Similarly, the a and b chains of many
f the integrin receptors of these ECM proteins are also
ither absent or only weakly expressed in GCs (Casta-
os-Velez et al., 1995). In particular, those receptors
known to interact with vitronectin are missing, a finding
corroborated by our observation that an av-specific an-
FIG. 5. Colocalization of CD155 and vitronectin on B cells. Human to
CD3 (clone UCHT-1), CD51 (av integrin subunit-specific antibody, N-19), o
NA. CD155 was not found to colocalize with either T cells (a) or the a
with vitronectin (d). (e) A closer view of a GC double stained for CD15
B cells.ibody failed to stain specific structures inside the GC
Fig. 5b). FDCs retain on their surface complement pro-
p
cein C3 bound to an antigen that is subsequently pre-
ented to B cells (see Carroll, 1998b, for a review). These
3 complexes may be taken up and processed by GC B
ells contacting FDCs (Carroll, 1998b). The expression of
omplement receptors CD21 and CD35 on the surface of
oth FDCs and GC B cells is a prerequisite for a suc-
essful antigen-triggered immune response (Carroll,
998a; Fang et al., 1998; Fischer et al., 1998). Therefore,
cryosections were stained with antibodies specific for CD155 (D171),
ectin (clone VN5-3). B cells inside the GC were stained using the lectin
of integrins (b), whereas B cells express CD155 (c) and are decorated
C B cells and (f) a corresponding GC stained for vitronectin and GCnsillar
r vitron
v chainroteins of the early complement cascade and their re-
eptors are involved in proper GC development as well
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224 LANGE ET AL.as memory B cell generation (Carroll, 1998b; Liu et al.,
1996). However, complement can also be harmful in this
environment by forming membrane attack complexes
deadly to the cells, a fate that can be prevented by
vitronectin (Preissner, 1991). Indeed, immunostainings
indicated activation of the late complement cascade in-
side the GC (Yamakawa and Imai, 1992), in particular on
FDCs (Halstensen et al., 1988). It is intriguing to specu-
late that CD155 contributes to the protection of cells
expressing complement receptors by trapping vitronec-
tin on the cell surface.
The implication of cells of the immune system in PV
pathogenesis was subject to intense discussions
(Bodian, 1955; Sabin, 1956). The lymphatic tissue lining
the gastrointestinal tract has been suggested to repre-
sent the primary site of an oral infection with PV (Bodian,
1955). Although virus propagation inside Peyers patches
and tonsils is considered necessary to establish the
viremic stage of an infection, the cells supporting virus
growth have not been identified thus far. The results
presented here restrict the repertoire of candidate cells
to FDCs and follicular B cells comprising GCs, thus
substantiating the importance of the immune system in
initiating a PV infection. GCs do not belong to the struc-
tures regularly found inside secondary lymphoid organs.
Indeed, we frequently obtained tissue from tonsillecto-
mies lacking GCs and consequently never observed any
staining specific for CD155 in such tonsils. This finding
suggests that an already ongoing secondary immune
response promotes the onset of a successful PV infec-
tion of the lymphoid organs surveying the alimentary
tract. In contrast there is no indication that innate and
primary immune responses are affected by the viral
infection. Remarkably, only the small subset of GC B cells
was found to express CD155. B cells residing in B cell
zones and primary follicles mediating primary immunity
lack CD155, thereby not supporting viral replication.
Therefore, this pool of B lymphocytes, including those
circulating in the blood stream (Freistadt et al., 1993), do
not contribute to virus dissemination as observed in the
case of Type B coxsackieviruses (Mena et al., 1999).
The study of the CD155 promoter and the transcription
factors regulating its activity led us to suspect expres-
sion of CD155 during embryonic development (Solecki et
al., 1997, 1999, 2000). Recent analyses of the CD155
promoter in the context of CD155/b-gal transgenic mice
ave revealed transgene expression in notochord, floor
late, and those regions of the ventral spinal cord fos-
ering the developing motor neurons (Gromeier et al.,
000). These locations are also sites of elevated vitro-
ectin expression and it has been suggested that vitro-
ectin can promote the differentiation of precursor cells
nto motor neurons (Martı´nez-Moralez et al., 1997). A
D155/vitronectin interaction may thus serve differentunctions depending on the distinct site of their colocal-
zation.
c
gUnlike nectins, CD155 is not a homophilic cell adhe-
sion molecule (Aoki et al., 1997, our own unpublished
data). We propose that CD155 mediates cell-to-matrix
contacts via a strong and rapid interaction with vitronec-
tin (see Table 1). Remarkably, the most N-terminally lo-
cated V domains of the corresponding receptors are the
mediators of their respective functions as discussed
here (see Fig. 1 for sequence conservation; our own
results and Miyahara et al., 2000). The functional diver-
sification of CD155 family members is also reflected by
the nature of their cytoplasmic domains, which exert no
homology at all. Whereas nectins have the propensity to
interact with afadin, the cytoplasmic domain of CD155a
specifically binds to tctex (S. Mu¨ller, X. Cao, and E.
Wimmer, in preparation), a protein component of the
cytoplasmic dynein complex (Hirokawa, 1998; King et al.,
1996). Hence CD155 may utilize a different pathway(s) to
transmit extracellular binding events to the cell’s interior.
MATERIALS AND METHODS
Cell culture
CHO, HEp 2, and HEp 2-Cl32 cells were grown in
DMEM/10% FBS. HEp 2 cells express CD155 (Calvez et
l., 1995), whereas HEp 2-Cl32 cells, a subclone of HEp
kindly provided by F. Colbe`re-Garapin (Institut Pasteur,
aris), are devoid of CD155 expression. Sf9 cells were
ultivated in Excell 401 (Biozol)/10% FBS.
loning and expression of soluble variants of CD155
nd PRR2 (sCD155d1d3 and smPRR2d1d3)
The primers used for PCR generating sCD155d1d3
nd smPRR2d1d3 (Fig. 1) were 59-PVR (59-CGGAA-
ATCTGGCATGGCCCGAGC-39), 39-PVRHIS (59-GCTCTA-
ATTCAATGGTGATGGTGATGGTGCTCACTGGGAGG-39),
9-MPH (59-CCAGATCTGGCATGGCCCGGGCCGCAGTCC-
9), and 39-MPHHIS (59-GCGAATTCAATGGTGATGGTGATG-
TGATGGTGATGGTGATCTCGGGAGGCCTGGGGG-39).
CR conditions were 3 min at 95°C; 5 cycles of 95°C for
5 s, 50°C for 1 min, 72°C for 2 min; 30 cycles of 95°C for
5 s, 55°C for 45 s, 72°C for 2 min, and 72°C for 5 min
n a 50-ml reaction volume using CombiPol Polymerase
(InViTek). The sCD155d1d3 (smPRR2d1d3) fragment was
cut with BglII/XbaI (EcoRI/BglII) and cloned into the vec-
or pVL1392 (PharMingen). Positive clones were se-
uenced and transfected along with linearized baculovi-
us DNA into Sf9 insect cells using the BaculoGold
ransfection kit (PharMingen). Recombinant virus was
ecovered from the supernatant after 6 days at 27°C and
assaged several times in order to produce a high-titer
tock solution. For protein purification, insect cells were
arvested 3 days postinfection and the cells lysed in 10
M Tris–HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100. Theleared lysate was incubated with NiNTA-agarose (Qia-
en) at 4°C several hours, the beads were washed five
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225CD155 ADHESION TO VITRONECTINtimes (50 mM NaPi, pH 8, 300 mM NaCl), and the bound
aterial was eluted with 50 mM NaPi, pH 6, 300 mM
NaCl, 500 mM imidazole. Buffer was exchanged using
PD-10 columns (Pharmacia). Each preparation was
checked for purity by SDS–PAGE and subsequent silver
staining (Pharmacia).
Cloning and expression of a soluble,
underglycosylated deletion variant of CD155
(Fig. 1; sCD155d1d2aglc)
Primers used for PCR were 59-CD155, 59-AACTGCA-
GATGGCCCGAGCCATGGCC-39, and 39-CD155, 59-AACT-
GCAGTTAATGGTGATGGTGATGGTGCACAGTCAGCAGCT-
GAGGC-39. A CD155 receptor construct used in earlier
studies (Bernhardt et al., 1994b), lacking four of five glyco-
sylation sites in domains 1 and 2, served as template. The
PCR product was cut with PstI and cloned into pED4 (kindly
provided by Genetics Institute). Plasmid DNA was trans-
fected into DHFR-deficient CHO cells; a positive cell clone
was selected and grown using methotrexate at a final
concentration of 200 nM. Protein was purified from super-
natant as described above.
Plaque reduction assay
This assay was done as described previously (Cao
and Wimmer, 1996). In brief, 10,000 pfu of PV1 (Mahoney)
was incubated with or without 10 mg purified
CD155d1d3 for 3 h at 4°C followed by 1 h at 237°C.
enfold dilutions were then plaqued on HeLa cells ac-
ording to standard procedures.
ell adhesion assay
According to the instructions of the manufacturer, 96-
ell plates were coated with 500 ng human vitronectin
Promega), BSA (Sigma), or human collagen type IV
Gibco) per well for 1 h at room temperature. Wells were
locked with 2 mg/ml BSA in PBSd (8 g/l NaCl, 0.2 g/l
Cl, 1.15 g/l Na2HPO4, 0.2 g/l KH2PO4) for another hour at
oom temperature. HEp 2 or HEp 2-Cl32 cells were de-
ached using PBSd, 10 mM glucose, 2 mM EDTA and
ashed with serum-free DMEM. Cells (5 3 104 in a total
volume of 100 ml) were added to each well and allowed
to sit for 1 h at 37°C. For inhibition experiments, cells
were preincubated for 5 min in the presence of the
indicated proteins (10 mg 6C23/ml, 50 mg D171/ml, 50 mg
44/ml, 50 mg control mAb/ml, 10 mg sCD155d1d3/ml, 10
mg sCD155d1d2aglc/ml) before the cells were added to
the wells. Wells were then washed three times with
DMEM and bound cells quantified using the CellTiter 96
cell proliferation assay (Promega).
Dot blot assaysOne microgram of protein each of BSA, human colla-
gen type IV, and human vitronectin (see also previous
s
fparagraph) was spotted onto nitrocellulose membranes
(Amersham). All steps were performed at room temper-
ature. The membrane was blocked with 2 mg/ml BSA,
washed two times with TBST (Tris–HCl, pH 7.5, 150 mM
NaCl, 0.05% Tween 20), incubated for 10 min with 1 mg
sCD15d1d3 in TBST, and washed three times with TBST
before the bound sCD155d1d3 was detected using the
PentaHis antibody (Qiagen) followed by an anti-mouse
antibody coupled to alkaline phosphatase (Sigma). After
three washes with TBST the blots were developed with
the NBT/BCIP system (Promega) and quantified densito-
metrically.
BIAcore measurements
Surface plasmon resonance measurements were car-
ried out with a BIAcore instrument (Biacore). Proteins
[vitronectin from rat (Sigma) or human (Promega), BSA,
D171, smPRR2d1d3, and human collagen type IV (Gibco)]
were immobilized in 10 mM Na acetate, pH 5, on a CM5
sensor chip using standard EDC (1-ethyl-3-(dimethyl-
aminopropyl)carbodiimide-HCl) and NHS (N-hydroxysuc-
cinimide) coupling chemistry and subsequent saturation
of free binding groups with ethanolamine. Running buffer
was HBS (Biacore). For analysis typically a sample vol-
ume of 100 ml was injected at a flow rate of 10 ml/min. A
coating density of approximately 2000 relative units was
loaded in each case. Calculations were done using the
Biaevaluation 2.0 software assuming a simple first-order
reaction.
Immunohistochemistry
For immunohistochemical analyses, human tonsils
from routine tonsillectomies (kindly provided by Dr. Fink,
Berlin-Buch) were embedded in Tissue Tek (Miles) and
snap frozen in liquid nitrogen. Cryostat sections of a
thickness of 10 mm were dried overnight on gelatin-
overed slides and fixed with acetone. Slides were re-
ydrated and blocked for 1 h in staining buffer (100 mM
ris–HCl, pH 8, 150 mM NaCl, 0.1% Tween 20) supple-
ented with 5% rat serum. The sections were incubated
n staining buffer containing the corresponding antibody
or 1 h in each step. CD155 was detected using mAb
171 and biotinylated anti-mouse IgG antibody as sec-
ndary antibody. For single stainings, the signal was
nhanced using the tyramide signal amplification system
irect Green (NEN DuPont) and for double stainings with
he tyramide signal amplification system Direct Red
NEN DuPont). The anti-myc mAb 9E10 was used as a
ontrol. For the detection of vitronectin, the mAb clone
n5-3 (TaKaRa) was used and bound antibody was de-
ected with an anti-mouse IgG mAb labeled with either
ITC or TRITC (Jackson). A pentaHIS mAb (Qiagen)
erved as a control antibody. In the case of the double
taining of CD155 and vitronectin, the latter was per-
ormed first followed by an incubation with biotinylated
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226 LANGE ET AL.mAb D171 in order to detect CD155 (including signal
amplification as outlined above). FDCs were stained with
directly labeled mAb HJ2 (Sigma, and a kind gift from
M. H. Nahm), whereas GC B cells were detected with
PNA–FITC (Vector) in a detergent-free buffer system (10
mM HEPES, pH 7.5, 150 mM NaCl, 0.1 mM CaCl2, 0.1 mM
MnCl2) (Butch and Nahm, 1992). Staining with PNA was
lways done at the end of a staining sequence. For the
J2 antibody, an irrelevant IgM–FITC conjugate (Cym-
us) was used as a control. The anti-CD3 mAb (UCHT-1;
ianova) conjugated with biotin was used for staining T
ells. Bound mAb was visualized with streptavidin–FITC.
etection of CD51 (N-19; Santa Cruz) was performed as
escribed for CD155 using the tyramide signal amplifi-
ation system. The slides were mounted in Moviol (Cal-
iochem) and analyzed by confocal laser microscopy
Leica, TCS 4D-I).
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